Cathie Wood’s ARK ETF adjusts portfolio, buys FIGMA stock and sells GENIUS SPORTS

Published 05/09/2025, 01:04
Cathie Wood’s ARK ETF adjusts portfolio, buys FIGMA stock and sells GENIUS SPORTS

In the latest trading session, Cathie Wood’s ARK ETF published their daily trades for Thursday, September 4th, 2025, with a noticeable shift in their portfolio composition. The trades executed by ARK Investment Management LLC, led by the prominent investor Cathie Wood, showcased a strategic rebalancing that may hint at the fund’s evolving market outlook.

At the forefront of ARK’s trading activity was the purchase of 108,238 shares of FIGMA INC (FIG), through its ARKW ETF, amounting to a value of approximately $7,374,254. This acquisition stands out as the largest dollar-value trade for the day, signifying a bullish stance on the design platform’s prospects.

Conversely, ARK opted to divest a significant portion of its holdings in GENIUS SPORTS LTD (GENI), with the sale of 428,277 shares through ARKW, totaling around $5,593,297. This move may reflect a strategic shift away from the sports data company or a simple portfolio adjustment.

Another key trade involved the biotechnology sector, where ARK bought 131,700 shares of INTELLIA THERAPEUTICS INC (NASDAQ:NTLA) through its ARKK ETF, with a total dollar value of $1,542,207. This purchase adds to a recent accumulation trend, as ARK has consistently increased its stake in the genome editing company over the past week, signaling a strong conviction in its long-term potential.

On the selling side, ARK also reduced its position in ROKU INC (NASDAQ:ROKU), offloading 26,465 shares through ARKK, which equated to $2,606,008. This follows a pattern of selling the streaming device manufacturer’s stock, as evidenced by ARK’s transactions over the past several sessions.

Investors following ARK’s trades might interpret these moves as part of a broader strategy to capitalize on emerging technologies and innovative companies, as the fund has historically focused on high-growth potential sectors. The emphasis on FIGMA and INTELLIA THERAPEUTICS, paired with the shedding of GENIUS SPORTS and ROKU stocks, could suggest a realignment of the ETF’s investment thesis to adapt to changing market conditions and future growth trajectories.

As always, ARK’s daily trades are closely watched by investors for insights into the fund’s market perspective and individual stock prospects. With Cathie Wood at the helm, ARK ETFs continue to be a barometer for innovation-focused investment strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.